Surani R. Fernando, MD
Endocrinology, Diabetes & Metabolism Physician · New Haven, CT
Surani R. Fernando, MD is an endocrinology, diabetes & metabolism physician with a practice address in New Haven, Connecticut, and NPI 1750355137, issued on Feb 14, 2006. Check the license (Connecticut 038749, as entered in NPPES) on the Connecticut Medical Examining Board; the Medicare figures below come from public CMS files.
- Name
- Surani R. Fernando
- Credential
- MD
- Primary taxonomy
- Endocrinology, Diabetes & Metabolism Physician 207RE0101X
- License number
- 038749 CT
Self-reported in NPPES; status is on the state search - Practice location
- 200 Orchard St, New Haven, CT 06511
- Phone
- (203) 776-4444
- Enumerated
- Feb 14, 2006
- Record last updated
- Nov 12, 2009 (not updated in 17 years: call before relying on the address or phone)
- Fax
- (203) 776-4441
- Medicare enrollment
- Enrolled (PECOS I20040617001185); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
Also registered at 200 Orchard St
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Urmila Bhuvanesh, M.D.Obstetrics & Gynecology Physician1730179201
- Heather Brigance, APRN, CNMAdvanced Practice Midwife1396083069
- Nancy Brown, MDPediatrics Physician1881780047
- Kathleen Brown Barone, D.C. OTROccupational Health Chiropractor1487857231
- Eric Fan, M.D.Internal Medicine Physician1114966561
- Joseph Fitzgerald, LCSWClinical Social Worker1609888239
Verify Surani R. Fernando in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersConnecticut Medical Examining Board
Search for license 038749Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
98% more Medicare Part D claims than the average endocrinology, diabetes & metabolism physician in 2024
5,219 Medicare Part D claims for 930 beneficiaries, against an average of 2,630 among the 8,223 providers of this specialty who prescribed in Part D. Brand-name drugs were 50% of claims.
Most prescribed
- Levothyroxine Sodium886 claims
- Synthroid448 claims
- Ozempic277 claims
- Trulicity216 claims
- Alendronate Sodium213 claims
- Metformin Hcl Er210 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The MIPS final score for 2023 (Medicare payment program): 94.2 of 100
The Merit-based Incentive Payment System score is reported for this clinician. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023; category weights for 2023 (qpp.cms.gov).
Industry payments in 2024: $544.38
19 payments; by number, the most common kind was food and beverage; the largest payer was Amgen Inc. The 5,661 providers of this specialty with any payment received $5,742.15 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Endocrine Assoc OF CT LLCHamden, CT
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Endocrinology, Diabetes & Metabolism Physician providers in Connecticut
There are 214 endocrinology, diabetes & metabolism physician records in Connecticut.
Other endocrinology, diabetes & metabolism physician records in Connecticut
- Hassaan Bin Aftab, M.D.Farmington, CT1477007839
- Umar Ahmad, D.O.Danbury, CT1336589746
- Fadi Al-Khayer, MDStorrs, CT1861477069
- Vivek Alaigh, MDStamford, CT1740675818
- Kenda Alkwatli, MDWethersfield, CT1063075901
- Ipek Alpertunga, MDHartford, CT1386166452
- Helen Anaedo, M.DPlainville, CT1164717021
- Anika Anam, M.D.New Haven, CT1376885905
- Muhammad Ansar, MDFarmington, CT1285918557
- Neelum AnwaarNorwalk, CT1336670041
Common questions
What is Surani R. Fernando, MD's NPI number?
Surani R. Fernando, MD's National Provider Identifier (NPI) is 1750355137, issued on Feb 14, 2006. An NPI identifies a provider in billing; it is not a license.
Where is Surani R. Fernando, MD located?
The NPPES record lists a practice address at 200 Orchard St, New Haven, CT, 06511. Phone: (203) 776-4444. Providers update this record themselves, so call before visiting.
How can I verify Surani R. Fernando, MD's license?
NPPES lists Connecticut license number 038749, as entered by the provider. Search the Connecticut Medical Examining Board at https://www.elicense.ct.gov/Lookup/LicenseLookup.aspx. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Surani R. Fernando, MD prescribe under Medicare Part D?
In 2024, Surani R. Fernando, MD had 5,219 Medicare Part D claims for 930 beneficiaries; the average among endocrinology, diabetes & metabolism physician prescribers was 2,630. Part D covers Medicare prescriptions only.
What is Surani R. Fernando, MD's MIPS final score?
The 2023 MIPS final score is 94.2 of 100. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.